Paper12972166
Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.
Kanemitsu H and 2 others. Neurosci Lett, 2003. Cited by 185 papers, by iCite.
Cite this record
ConductScience Library. Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Papers, record 12972166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12972166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyloid beta-Peptides | Major topic |
| Brain | Major topic |
| Neprilysin | Major topic |
| Peptide Fragments | Major topic |
| Cell Line | |
| Enzyme Inhibitors | |
| Humans | |
| Peptide Hydrolases | |
| RNA, Messenger |
Source PubMed
Cited by92
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42776799 | Antibody-Based Biologics for CNS Disorders. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/42776799 | PubMed |
| 42041396 | Brain Delivery of Antibody-Derived Biologicals for Alzheimer's Disease: An Updated Narrative Review. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/42041396 | PubMed |
| 41865200 | Arsenic Promotes Intracellular Aβ(1-42) Accumulation via Enhanced APP but Reduced NEP Expression, and Indirectly Stimulates Extracellular Aβ Aggregation through AChE Induction in Differentiated SH-SY5Y Cells. | Biol Trace Elem Res | 2026 | https://conductscience.org/library/papers/41865200 | PubMed |
| 40465637 | Cell-specific protein expression in Alzheimer's disease prefrontal cortex. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40465637 | PubMed |
| 40387258 | Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches. | J Neurosci Res | 2025 | https://conductscience.org/library/papers/40387258 | PubMed |
| 40233761 | Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins. | Cell Stem Cell | 2025 | https://conductscience.org/library/papers/40233761 | PubMed |
| 39698259 | Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/39698259 | PubMed |
| 39309779 | Association of MME gene polymorphisms with susceptibility to Alzheimer's disease in an Iranian population. | Heliyon | 2024 | https://conductscience.org/library/papers/39309779 | PubMed |
| 39013601 | Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting. | Pharmacol Rev | 2024 | https://conductscience.org/library/papers/39013601 | PubMed |
| 38642804 | Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation. | J Adv Res | 2025 | https://conductscience.org/library/papers/38642804 | PubMed |
| 38222463 | Modelling Alzheimer's disease in a dish: dissecting amyloid-β metabolism in human neurons. | Neuronal Signal | 2024 | https://conductscience.org/library/papers/38222463 | PubMed |
| 37847125 | Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/37847125 | PubMed |
| 37427403 | The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer's-related disease and preserving cognition. | Front Physiol | 2023 | https://conductscience.org/library/papers/37427403 | PubMed |
| 36471433 | Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/36471433 | PubMed |
| 36117918 | Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/36117918 | PubMed |
| 35586246 | Comparative studies for amyloid beta degradation: "Neprilysin vs insulysin", "monomeric vs aggregate", and "whole Aβ40 vs its peptide fragments". | Biochem Biophys Rep | 2022 | https://conductscience.org/library/papers/35586246 | PubMed |
| 34743290 | Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function. | Clin Transl Oncol | 2022 | https://conductscience.org/library/papers/34743290 | PubMed |
| 34721050 | Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure. | Front Physiol | 2021 | https://conductscience.org/library/papers/34721050 | PubMed |
| 34458738 | Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment. | RSC Med Chem | 2021 | https://conductscience.org/library/papers/34458738 | PubMed |
| 34299316 | Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34299316 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MME | 4311 | PubTator's text mining | https://conductscience.org/library/genes/4311 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12972166
GET https://conductscience.org/api/papers/v1/12972166/cited_by?page=2